Multiple Sclerosis and Risk of Venous Thromboembolism: A Population-Based Cohort Study

No abstract is available for this paper.

• Publication year

  2012

• Venue

  Neuroepidemiology

• Publication date

  2012-01-27

• Fields of study

  Medicine

• Identifiers
  DOI 10.1159/000335496PMID 22286104
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Venous thromboembolism discharge diagnoses in the Danish National Patient Registry should be used with caution.

  2010cited by this paper
• Risk of Arterial Cardiovascular Diseases in Patients with Multiple Sclerosis: A Population-Based Cohort Study

  2010cited by this paper
• Coagulation status and biochemical and inflammatory markers in multiple sclerosis.

  2008cited by this paper
• Evidence of platelet activation in multiple sclerosis

  2008cited by this paper
• Applied Survival Analysis: Regression Modeling of Time-to-Event Data

  2008cited by this paper
• Venous thromboembolism (VTE) in Europe

  2007cited by this paper
• Risk factors and short-term mortality of venous thromboembolism diagnosed in the primary care setting in the United Kingdom.

  2007cited by this paper
• The Accuracy of Prevalence Rates of Multiple Sclerosis: A Critical Review

  2007cited by this paper
• Venous thromboembolism and subsequent hospitalisation due to acute arterial cardiovascular events: a 20-year cohort study.

  2007cited by this paper
• Smoking rates and smoking cessation among individuals with multiple sclerosis

  2006cited by this paper
• Thrombin in inflammatory brain diseases.

  2006cited by this paper
• The Epidemiology of Venous Thromboembolism in the Community: Implications for Prevention and Management

  2006cited by this paper
• Plasma homocysteine levels in multiple sclerosis

  2006cited by this paper
• Type 1 diabetes and multiple sclerosis: A Danish population-based cohort study.

  2006cited by this paper
• Beyond randomized controlled trials: A critical comparison of trials with nonrandomized studies

  2006cited by this paper
• Comparison of risk factors for the competing risks of coronary heart disease, stroke, and venous thromboembolism.

  2005cited by this paper
• Multiple sclerosis and lifestyle factors: the Hordaland Health Study

  2005cited by this paper
• Cigarette smoking and the progression of multiple sclerosis.

  2005cited by this paper
• Health behaviors, body composition, and coronary heart disease risk in women with multiple sclerosis.

  2003cited by this paper
• Use of managed care claims data in the risk assessment of venous thromboembolism in outpatients.

  2002cited by this paper
• Elevated plasma endothelial microparticles in multiple sclerosis

  2001cited by this paper
• Disability and prognosis in multiple sclerosis: demographic and clinical variables important for the ability to walk and awarding of disability pension

  2001cited by this paper
• When an Entire Country Is a Cohort

  2000cited by this paper
• Incidence of cancer after prophylaxis with warfarin against recurrent venous thromboembolism. Duration of Anticoagulation Trial.

  2000cited by this paper
• The Danish National Hospital Register. A valuable source of data for modern health sciences.

  1999cited by this paper
• Underlying cause of death in Danish patients with multiple sclerosis: results from the Danish Multiple Sclerosis Registry

  1998cited by this paper
• Regional administrative health registries as a resource in clinical epidemiology

  1997cited by this paper
• The epidemiology of diagnosed pulmonary embolism and deep venous thrombosis in the elderly.

  1994cited by this paper
• Are patients with multiple sclerosis protected from thrombophlebitis and pulmonary embolism?

  1988cited by this paper

• Transient Bilateral Atrial Thrombi in a Patient With Multiple Sclerosis and Massive Pulmonary Embolism: A Case Report and Review of the Literature

  2025cites this paper
• Human B-cells can form hetero-aggregates with blood platelets: a novel insight into adaptive immunity regulation in multiple sclerosis.

  2024cites this paper
• Targeting Vascular Impairment, Neuroinflammation, and Oxidative Stress Dynamics with Whole-Body Cryotherapy in Multiple Sclerosis Treatment

  2024cites this paper
• Quantitative and structural changes of blood platelet cytoskeleton proteins in multiple sclerosis (MS).

  2024cites this paper
• Pathogenic Role of Fibrinogen in the Neuropathology of Multiple Sclerosis: A Tale of Sorrows and Fears

  2023cites this paper
• [Changes in venous circulation in patients with multiple sclerosis].

  2023cites this paper
• Multiple sclerosis and the incidence of venous thromboembolism: a systematic review and meta-analysis

  2023cites this paper
• Stroke risk in multiple sclerosis: a critical appraisal of the literature

  2022cites this paper
• Hemostasis Components as Therapeutic Targets in Autoimmune Demyelination

  2022cites this paper
• Pulmonary embolism in patients with multiple sclerosis treated with teriflunomide: A series of three cases.

  2021cites this paper
• Iliofemoral venous stenting in patients with central neuromuscular disorders.

  2021cites this paper
• Platelet Inhibition by Low-Dose Acetylsalicylic Acid Reduces Neuroinflammation in an Animal Model of Multiple Sclerosis

  2021cites this paper
• Platelet inhibition by P2Y12 antagonists is potentiated by adenosine signalling activators

  2021cites this paper
• Deep venous thrombosis in patients with neurological diseases: A multicenter, prospective study.

  2021cites this paper
• Postoperative Outcomes Following Posterior Lumbar Fusion in Patients With Multiple Sclerosis

  2021cites this paper
• The Impact of SARS-CoV-2 Infection on the Development of Neurodegeneration in Multiple Sclerosis

  2021cites this paper
• Oxidative Damage of Blood Platelets Correlates with the Degree of Psychophysical Disability in Secondary Progressive Multiple Sclerosis

  2020cites this paper
• Incident cardiovascular disease in patients diagnosed with multiple sclerosis: A multi-database study.

  2020cites this paper
• Venous thromboembolism in multiple sclerosis: a report of two cases with pulmonary embolism on dimethyl fumarate and available data from adverse event reporting systems. Time to include disease modifying drugs in the equation?

  2020cites this paper
• Effect of combined exercise training on pentraxins and pro- inflammatory cytokines in people with multiple sclerosis as a function of disability status.

  2020cites this paper
• Serious safety events in rituximab‐treated multiple sclerosis and related disorders

  2020cites this paper
• Metformin as a Potential Agent in the Treatment of Multiple Sclerosis

  2020cites this paper
• Increased Pro-Thrombotic Platelet Activity Associated with Thrombin/PAR1-Dependent Pathway Disorder in Patients with Secondary Progressive Multiple Sclerosis

  2020cites this paper
• Multiple sclerosis and the risk of systemic venous thrombosis: A systematic review.

  2019cites this paper
• Increased level of fibrinogen chains in the proteome of blood platelets in secondary progressive multiple sclerosis patients

  2019cites this paper
• Pro-Thrombotic Activity of Blood Platelets in Multiple Sclerosis

  2019cites this paper
• Effects of intermittent pneumatic compression treatment on clinical outcomes and biochemical markers in patients at low mobility with lower limb edema.

  2018cites this paper
• Thrombin generation correlates with disease duration in multiple sclerosis (MS): Novel insights into the MS-associated prothrombotic state

  2017cites this paper
• Vascular Disease in Patients with Multiple Sclerosis: A Review

  2016cites this paper
• Role of Innate Immunity in Multiple Sclerosis

  2015cites this paper
• Multiple sclerosis increases the risk of venous thromboembolism: a nationwide cohort analysis

  2015cites this paper
• Demyelinating and Thrombotic Diseases of the Central Nervous System: Common Pathogenic and Triggering Factors

  2015cites this paper
• Relationship between the Increased Haemostatic Properties of Blood Platelets and Oxidative Stress Level in Multiple Sclerosis Patients with the Secondary Progressive Stage

  2015cites this paper
• Aspirin and multiple sclerosis

  2015cites this paper
• Thrombotic Processes in Multiple Sclerosis as Manifestation of Innate Immune Activation

  2014cites this paper
• The risk of venous thromboembolism in patients with multiple sclerosis: the Clinical Practice Research Datalink

  2014cites this paper
• Multiple sclerosis clinical course and cardiovascular disease risk – Swedish cohort study

  2014cites this paper
• Myeloproliferative neoplasms in five multiple sclerosis patients☆

  2013cites this paper
• Risk of Thromboembolism in Patients Suffering from Multiple Sclerosis

  2013cites this paper
• Platelets and autoimmunity

  2013cites this paper
• High risk of cardiovascular diseases after diagnosis of multiple sclerosis

  2013cites this paper
• Risk of vascular disease in patients with multiple sclerosis: a review

  2012cites this paper